BSE filing, NSE: SHARDACROP. Summary written from the filing by ALFA Finder's alert engine.
Sharda Cropchem Ltd: key numbers
- Share price
- ₹681.00
- Market cap
- ₹6,144 Cr
- Revenue (annual)
- ₹5,268 Cr
- Net profit (annual)
- ₹680.9 Cr
- P/E (TTM)
- 9.8×Sector 34.5×
- Promoter holding
- 74.82%+0.00% QoQ
- FII holding
- 3.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sharda Cropchem Ltd
All →Sharda Cropchem Board Meeting Date
Sharada Cropchem scheduled a board meeting for 30 Oct 2026 to consider its H1 FY27 unaudited financial results. No financial figures or decisions are reported in this advance intimation.
Sharda Cropchem Annual General Meeting
Sharda Cropchem Ltd held its 23rd AGM on August 14, 2026. Shareholders adopted financial statements and approved a final dividend of Rs. 9.00 per share.
Sharda Cropchem Investor Presentation: Key Takeaways
Sharda Cropchem reported Q1 FY27 revenue growth of 9% YoY to Rs 1,074 crores. EBITDA grew 25% to Rs 178 crores with margins expanding to 16.6% despite FX headwinds.
- Call
- Guides 12% growth
Sharda Cropchem Results Update
Sharda Cropchem reported Q1 FY27 revenue of ₹1,074 crore, up 9% YoY. EBITDA grew 25% YoY to ₹178 crore.
- Value
- ₹1,074 Cr
Sharda Cropchem Investor Presentation: Key Takeaways
Sharda Cropchem reported Q1 FY27 revenue of ₹1,074 Cr (+9% YoY) and EBITDA of ₹178 Cr (+25% YoY). The company continues to leverage its asset-light, IP-led registration model.
Sharda Cropchem Q1 FY27 Results: Net Profit ₹88 Cr, Down 38.4% YoY
Sharda Cropchem Ltd reported revenue from operations of ₹1,074 Cr (+9.0% YoY) and net profit of ₹88 Cr (-38.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹88 Cr · -38.4% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.